Some members of a series of cinnamic acid derivatives possess promising inhibitory activities in cellular assays against fungi of the Aspergillus genus. In order to search for a possible molecular target of such compounds, their role as Taq polymerase I inhibitors was studied. Four of the compounds studied displayed IC 50 values within the range of those considered active as DNA polymerase inhibitors when searching for new cytotoxic molecules. The results obtained in our molecular modeling study appear to show that the inhibitory activity depends on the presence of a stabilizing interaction between the phenylpropanoid derivatives and the residues Asp610, Thr664, Phe667, Tyr671, and Asp785 located in the active site of Taq polymerase I. Also, it is possible to assert that the polymerization of DNA would be the molecular target of cinnamic acid derivatives with antifungal activity, which correlates with the inhibition of Taq polymerase I and the quantitative descriptor for the lipophilia (ClogP).
Over the last twenty years the interest in natural products as sources of lead structures has resurfaced. Of the various reasons for this fact the uniqueness of their structures may be considered as one of the most important. Natural compounds and their derivatives could potentially serve as effective alternatives to conventional antifungal agents. Several phenolic compounds and derivatives have been reported to possess antifungal activity. Among others, gallic acid has been reported to prevent aflatoxin biosynthesis by A. flavus [1] . Two new natural products {1-(3´-methoxypropanoyl)-2-4-5trimethoxybenzene and 2-(2Z)-(3-hydroxy-3,7-dimethylocta-2,6dienyl)-1,4-benzenediol} isolated from the root bark of Cordelia alliodora have been reported as antifungal and larvicidal compounds [2] . More recently, Kim et al. [3] reported antifungal effects of several phenolic compounds, including cinnamic acid (1), m-coumaric acid (12) , p-coumaric acid (3) and caffeic acid (6) . Antimicotic effects towards the dermatophytes Microsporum canis, Epidermophyton floccosum, Trichophyton mentagraphytes and Trichophyton rubrum were reported for 3-(3,3-dimethylallyl)-pcoumaric acid isolated from the aerial parts of Baccharis grisebachii collected in the Province of Mendoza, Argentina [4] . However, this compound did not show antifungal activity against Aspergillus fumigatus, A. flavus and A. niger [5] .
Aspergillus was first reported in 1729 by the Italian biologist Micheli. Nowadays, more than 189 species of this genus have been described; they are among the most abundant fungi in natural environments, such as soils, plants and decomposing organic waste [6] . Several species are phytopathogenic and cause, among other kinds of damages, severe losses to cereal crops. Moreover, this genus is one of the leading producers of aflatoxins, which are highly toxic and carcinogenic compounds [7] .
The Aspergillus genus includes saprophytic and opportunistic species; the latter may cause important infections that have become relevant in recent years. In fact, along with Candida and Fusarium they are considered as the major opportunistic pathogens in humans [8] . The number of persons at risk has increased in the last two decades. Thus, AIDS and transplant patients, and those who receive chemotherapy with cytotoxic drugs, corticosteroids and other immunosuppressive agents are the most likely to develop such infections. In spite of the increasing knowledge about Aspergillus infection epidemiology, mortality caused by invasive aspergillosis still remains very high [9] . Spore inhalation significantly increases the risk of lung infections in immunocompromised patients and/or in persons who are particularly exposed, such as horticulturists or gardeners [10] . Besides, invasive aspergillosis is frequent in cancer patients [11, 12] . Although A. fumigatus is the species most frequently isolated in clinical cases, A. flavus, A. terreus and A. niger are also frequent [13] .
Currently, there are four classes of bioactive compounds against Aspergillus spp: polyenes, which include amphotericin B and their lipidic formulations; azoles and triazoles, such as fluconazole, voriconazole, itraconazole and posaconazole; aminocandines, such as caspofungin and micofungine, and allyl amines, such as terbinafin [14] . Acute toxicity and development of resistance are two drawbacks shared by these four groups which significantly restrict their applicability and fully justify the search and design of new antifungal drugs [15] .
In a previous work [16] we studied the antifungal activity of a series of cinnamic acid-derived phenylpropanoids against A. flavus, A. terreus and A. niger ( Table 1 ). In that study two compounds were observed to have the most significant antifungal activity: the methoxylated derivatives of the natural product drupanin (15) and the ubiquitous metabolite, ferulic acid (6) . The first presented a Minimal Inhibition Concentration (MIC) similar to that of miconazol against the three tested fungal strains, while compound 6 was active mostly against A. niger and A. terreus. However, the possible action mechanism at a molecular level of these phenylpropanoids was not addressed in that study.
Enzymes involved in the metabolism of nucleic acids, such as polymerases, topoisomerases and girases, are molecular targets in the search for new antimicrobial drugs [17] . This strategy could be considered analogous to the screening of DNA polymerase inhibitors in the search of new potential anticancer compounds, which is now widely accepted. Plant natural products of different biogenetic origins, such as terpenes, fatty acids, and phenolics have been reported as promising inhibitors. Among them, the iridoid catalpol, isolated from Budleja cordobensis, and catechins, phenolic compounds from Camellia sinensis, are good inhibitors of DNA polymerase from the thermophilic bacillus Thermus aquaticus (Taq) [18] [19] [20] . This enzyme is currently one of the most extensively used in PCR applications because of its ability to replicate DNA at high temperatures. DNA polymerases are highly conserved proteins in respect of their active sites throughout different phylogenies [21] . On the basis of such concepts, it would be reasonable to hypothesize that if a compound inhibits a bacterial polymerase activity, it might also have a similar effect against a fungal one. In this context, the aim of our study was to determine a possible molecular target for phenylpropanoids that showed antifungal activities in cellular assays by assessing their inhibitory activity toward Taq DNA polymerase. Moreover, an approach to such putative molecular mechanisms was simulated using molecular modeling techniques.
Previously reported phenylpropanoids [16] were evaluated as possible Taq polymerase I inhibitors at a concentration of 500 M ( Table 2 ). Compounds 2, 3, 4, 5, 9, 10, 11, 12, 17, 18, 20 and 21 did not show any activity at such concentration. In contrast, compounds 1, 8, 13, 14 and 19 displayed inhibitory effects lower than 100% (6) and its methylester (7) were 1.57 +/-0.31 M and 1.28 +/-0.27 M, respectively. These results are particularly interesting considering that compounds previously reported as DNA polymerase inhibitors displayed IC 50 values ranging from 400 to 0.7 M 14.
By comparing the results of Taq polymerase I inhibition with the MIC values previously reported for antifungal activity (Table 2) , interesting conclusions can be drawn. Compound 15 displayed inhibitory activity against Taq polymerase I, as well as significant antifungal activity against Aspergillus fungi. This result suggests that the molecular mechanism of action of this compound could be the inhibition of that enzyme. Compound 16 displayed an enzymatic inhibitory effect similar to 15, but did not show antifungal activity. However, we have previously demonstrated that this phenolic compound is metabolized into 2-(2-hydroxypropan-2-yl)-2,3dihydrobenzofuran-5-carboxylic acid by A. terreus [16] , which could explain the lack of antifungal activity.
A more striking observation is that compound 7, which had the strongest inhibitory activity against Taq polymerase I, displayed just a marginal antifungal activity. A similar result was observed for compounds 6 and 19, which did not show any antifungal effect. In order to find an explanation for the discrepancy between the results of the cellular and the molecular assays, ClogP, a lipophilic quantitative molecular descriptor, was calculated for each compound {Table 2 and To acquire a more-detailed insight into the mechanisms driving the bindings of cinnamic acid derivatives to the active site of Taq polymerase I, the structure-affinity relationship was analysed to complement the experimental results. The information obtained from these calculations is very important for quantitative analyses and is highly useful to the understanding of the binding mechanism. Figure 1 shows the inhibitor-residue interaction spectra calculated by free energy decomposition, which suggests that the interaction spectra of compounds 6 and 15 with Taq-polymerase are almost the same and reflect their similar binding modes (note that the disfavoured interaction of Lys 663 with compound 15 is the only difference obtained when comparing both spectra). Closely related spectra were obtained for compounds 7 and 16 (data not shown), indicating that all the compounds possessing a significant inhibitory effect displayed very similar interaction spectra. For these compounds, the favourable residues can be divided into five groups around Asp610, Thr664, Phe667, Tyr671, and Asp785. The contribution to binding of an individual residue varies in the range of 3.1 to -6.2 kcal/mol. The dominant favourable interactions come from residues Thr664 and Asp785 performing stabilizing hydrogen bonds, as well as from residues Phe667 and Tyr671 making pi stacking interactions with the aromatic ring of the ligand. lowest-energy structures at the binding complexes extracted from MD simulations. Figure 2 also shows the different stabilizing and destabilizing interactions.
It is interesting to note that the interaction spectra obtained for compounds 17 and 18 are different from those observed for compounds possessing an inhibitory effect (Figure 3 ). In the case of compound 17 (Figure 3a ), there are three strong destabilizing interactions, namely with residues Arg573 (5.4 kcal/mol), Lys663 (7.2 kcal/mol) and Gln754 (7.4 kcal/mol). These destabilizing contributions make the binding energy obtained for compound 17 markedly higher than that obtained for compound 6. Figure 4a displays the relative spatial positions of compound 17 in the lowestenergy structure of the binding complexes extracted from MD simulations. The main stabilizing and destabilizing interactions can be well observed in this figure. Although the residues stabilizing the complex are very similar to those observed in the complexes obtained for compounds 6 and 15, in this case the distances between compound 17 and the stabilizing residues are larger and, therefore, the stabilizing energies are weaker (compare Figures 2a and 4a) . In addition, it should be noted that in this complex the stabilizing interaction of Thr664 disappears. The strongest destabilizing interaction was obtained for compound 18, namely the interaction between compound 18 and Arg573, which displays about 15.4 kcal/mol (Figures 3b and 4b ). This important destabilizing interaction, together with other minor ones, is responsible for the high binding energy obtained for compound 18 in comparison with those for compounds 6 and 15, which possess inhibitory effects.
These theoretical results are in a complete agreement with our experimental data. Thus the results obtained in our molecular modelling study make it clear that it is possible to discriminate between compounds possessing significant inhibitory effects (6, 7, 15 and 16) from those which are inactive toward Taq polymerase I (17 and 18) .
On the basis of our experimental and theoretical results, it is reasonable to assume that the cinnamic acid derivatives here reported are candidates to be leading structures in the design of new Taq polymerase I inhibitors. Taq polymerase I may be the molecular target for the antifungal activity displayed by the studied derivatives, but it is evident that a ClogP value of about 3 is also necessary to produce the antifungal effect at a cellular level.
The strong antifungal activity, the relatively low acute toxicity previously reported, and the molecular mechanism here reported indicate that the methoxylated derivative of drupanin (15) is a very good candidate on which to perform further studies in the search for new agents to control Aspergillus infections.
Experimental
Test compounds : Compounds 1, 2, 3, 6, and 11 were purchased from Sigma-Aldrich Co. Drupanin (13) was isolated as colorless crystals (mp 147-148°C) from aerial parts of B. grisebachii Hieron. Its chemical identity was confirmed by spectroscopic data, compared with previous reports [4] . Compounds 4, 5, 6, 7, 8, 9, 10 , 12, 14-21 were prepared as previously described by Bisogno and coworkers [16] . Taq polymerase I inhibition assays: Inhibition of Taq polymerase I from Thermusaquaticus (Sigma-Aldrich) was studied by PCR. The assayed compounds were dissolved in DMSO (1 mg/mL) and inhibition studies were carried out at a screening concentration of 500 M. The PCR master mixture consisted of 1.8 M MgCl 2 , 0.2 MdNTPs, 1 M primer sense (5´GGATCCATGAGCGGGGACCATCTCCA), and 1 M primer antisense (5´TCAAAACTCGTAGTCCTCATAG). DNA concentration was 0.013 mg/mL and all PCR reactions were made in 20 L. Thermocycling conditions consisted of 35 cycles of denaturation at 94°C for 30s followed by primer annealing at 53°C for 30s and primer extension at 72°C for 1 min 30s. Catapol 100 M was used as positive control. Assays were made in triplicate.
Compounds that displayed 100% inhibition at the screening concentration were further evaluated at lower concentrations by serial dilution (500 M to 0.95 M) in order to obtain the IC 50 value.
Analysis of PCR products:
Relative intensities of ethidium bromide stained PCR products were analyzed using an optical scanner. The digitized band images were processed using the Image processing software Scion Image, a public domain program. IC 50 values were determined by the GraphPad Prism software.
Molecular modeling:
The coordinate of Taq polymerase I was downloaded from Brookhaven Protein Data Bank (www.rcsb.org). The PDB code entry is 3KTQ. To explore the dynamic stability of the Taq-inhibitor complexes reported here, root mean square deviation (RMSD) values for the protease C  atoms during the MD simulations (relative to the docking structure) were calculated. The RMSD values of the Taq-6, Taq-15, Taq-17 and Taq-18 complexes are 1.60±.031, 2.13±0.59, 1.96±0.34 and 1.80±0.31 Å, respectively, showing a deviation lower than 0.6 Å from the mean. These results suggest that the stability of the dynamic equilibriums of these complexes is reliable.
Molecular docking:
In order to search for the preferable conformation, AutoDock 4.0 software [22] was used for docking calculations, combined with Lamarckian genetic algorithm (LGA). The center of the grid box was the active site and the size of the box was 50 x 45 x 55 grid points, with grid spacing of 0.375 Å. During the docking experiment, the receptor was kept rigid and the ligand was set flexible. The maximum number of energy evaluations was set to 25 x 10 6 ; the initial population of trial ligands consisted of 250 individuals; for the rest of the docking parameters the default values were used. Fifty docking runs were performed to find the preferable conformation. The docking results were clustered according to the RMSD of 2Å. Structures with relative lower binding free energy and most cluster members were chosen, which were then subjected to molecular dynamics simulations (MD).
Molecular dynamics simulations:
To relax the binding complexes and investigate their dynamics, three-nanosecond MD simulations were performed for the different Taq-inhibitor systems using Amber software [23] . The protein force field was taken from ff99SBilnd [24] . The general Amber force field (GAFF) [25] was used to handle small organic molecules and the force field parameters of the inhibitors were produced by the antechamber program in Amber. Each Taq-inhibitor complex was soaked in a truncated octahedral periodic box of TIP3P water molecules. The distance between the edges of the water box and the closest atom of the solutes was at least 10Å. Na + ions were added to neutralize the systems charge. The entire system was subjected to energy minimization in two stages to remove bad contacts between the complex and the solvent molecules. First, the water molecules were minimized by holding the solute fixed with harmonic constraints of 100 kcal/molÅ 2 strength. Secondly, conjugate gradient energy minimizations were performed repeatedly 4 times using positional restraints to all heavy atoms of the receptor with 15, 10, 5 and 0 kcal/molÅ 2 . The system was then heated from 0 to 300 K in 300 ps and equilibrated at 300 K for another 200 ps. After minimization and heating, 2.5 ns dynamics simulations were performed at a constant temperature of 300 K and a constant pressure of 1 atm. During minimization and MD simulations, the particle mesh Ewald (PMD) method was employed to treat the long-range electrostatic interactions in a periodic boundary condition. The SHAKE method was used to constrain hydrogen atoms. The time step for all MD is 2 fs, with a direct-space, non-bonded cutoff of 8Å. Initial velocities were assigned from a Maxwellian distribution at the initial temperature.
The MM-GBSA method: In MM-GBSA [26] , the binding free energy (ΔG bind ) resulting from the formation of a RL complex between a ligand (L) and a receptor (R) is calculated as
where ΔE MM , ΔG sol and -TΔS are the changes of the gas phase MM energy, the solvation free energy, and the conformational entropy upon binding, respectively. ΔE MM includes ΔE internal (bond, angle, and dihedral energies), ΔE electrostatic (electrostatic), and ΔE vdw (van der Waals) energies. ΔG solv is the sum of electrostatic solvation energy (polar contribution), ΔG GB , and the non-electrostatic solvation component (nonpolar contribution), ΔG SA . Polar contribution is calculated using the GB model, while the nonpolar energy is estimated by solvent accessible surface area (SASA). The conformational entropy change, -TΔS, is usually computed by normal-mode analysis, but in this study the entropy contributions were not calculated due to the computational cost involved in such calculations.
ClogP calculations:
All geometries of the compounds reported here were optimized from DFT calculations using the Becke3-Lee-Yang-Parr [27] [28] [29] (B3LYP) functional with the 6-31G(d) basis set. These calculations were carried out using the Gaussian 03 [30] program. Once the different optimized geometries were obtained, ClogP values were calculated using Chem Office Ultra 4.5 (Cambridgesoft. Corp 1988) software.
Supplementary data:
Theoretical ClogP values for compounds 1-21(Table1). Image of the Taqpolymerase I inhibition assay (Figure1).
